Austrija - vācu - AGES (Agentur für Gesundheit und Ernährungssicherheit)

pinzgau - apotheke - graminis rhizoma; pruni spinosae flos; rosae pseudo-fructus; taraxaci radix; violae tricoloris herba - other urologicals

Austrija - vācu - AGES (Agentur für Gesundheit und Ernährungssicherheit)

gall & reidlinger ohg - graminis rhizoma; ononidis radix; petroselini radix; taraxaci radix - other urologicals

Beļģija - vācu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bausch health ireland - povidon-jod - augentropfen, lösung - 50 mg/ml - povidon-jod 50 mg/ml - povidone-iodine

Eiropas Savienība - vācu - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - vorläuferzelle lymphoblastische leukämie-lymphom - antineoplastische mittel - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

morga ag - betulae folium (betula pendula roth und/oder betula pubescens ehrh., folium), graminis rhizoma (agropyron repens (l.) p.beauv. (elymus repens (l.) gould), rhizoma), solidaginis herba (solidago gigantea aiton oder solidago canadensis l., herba), ononidis radix (ononis spinosa l., radix), liquiritiae radix (glycyrrhiza glabra l. und/oder glycyrrhiza inflata bat. und/oder glycyrrhiza uralensis fisch, radix) - arzneitee - betulae folium (betula pendula roth und/oder betula pubescens ehrh., folium) 300 mg, graminis rhizoma (agropyron repens (l.) p.beauv. (elymus repens (l.) gould), rhizoma) 300 mg, solidaginis herba (solidago gigantea aiton oder solidago canadensis l., herba) 300 mg, ononidis radix (ononis spinosa l., radix) 300 mg, liquiritiae radix (glycyrrhiza glabra l. und/oder glycyrrhiza inflata bat. und/oder glycyrrhiza uralensis fisch, radix) 300 mg, pro charta 1.5 g. - harntreibend - phytoarzneimittel

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

morga ag - betulae folium (betula pendula roth und/oder betula pubescens ehrh., folium), graminis rhizoma (agropyron repens (l.) p.beauv. (elymus repens (l.) gould), rhizoma), solidaginis herba (solidago gigantea aiton oder solidago canadensis l., herba), ononidis radix (ononis spinosa l., radix), liquiritiae radix (glycyrrhiza glabra l. und/oder glycyrrhiza inflata bat. und/oder glycyrrhiza uralensis fisch, radix) - arzneitee - betulae folium (betula pendula roth und/oder betula pubescens ehrh., folium) 20 %, graminis rhizoma (agropyron repens (l.) p.beauv. (elymus repens (l.) gould), rhizoma) 20 %, solidaginis herba (solidago gigantea aiton oder solidago canadensis l., herba) 20 %, ononidis radix (ononis spinosa l., radix) 20 %, liquiritiae radix (glycyrrhiza glabra l. und/oder glycyrrhiza inflata bat. und/oder glycyrrhiza uralensis fisch, radix) 20 %, pro charta 1.5 g. - harntreibend - phytoarzneimittel

Vācija - vācu - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

bayer ag - emulsionskonzentrat - 75 g/l bixafen; 100 g/l prothioconazol; 100 g/l tebuconazol - top

Šveice - vācu - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

biokema s.a. - cabergolinum - solution huileuse pour administration par voie orale pour chiennes - cabergolinum 50 µg, triglycerida media, ad solutionem pro 1 ml. - inhibiteur de la prolactine pour chiennes - synthetika

Vācija - vācu - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

bayer ag - emulsionskonzentrat - 160 g/l prothioconazol; 200 g/l spiroxamine; 40 g/l proquinazid - top

Austrija - vācu - AGES (Agentur für Gesundheit und Ernährungssicherheit)

omnivision gmbh - ketorolac-trometamol -